Literature DB >> 17530652

Risk of interstitial lung disease associated with leflunomide treatment in Korean patients with rheumatoid arthritis.

Ji Hyeon Ju1, Sung-Il Kim, Jun-Hee Lee, Sang-Il Lee, Wan-Hee Yoo, Jung-Yoon Choe, Seung-Hie Chung, Jisoo Lee, You-Hyun Lee, Shin-Seok Lee, Hyun-Jung Yoon, Chong-Hyeon Yoon, Ho-Youn Kim, Sung-Hwan Park.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17530652     DOI： 10.1002/art.22666

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  12 in total

Review 1.  Treatment of rheumatoid arthritis-associated interstitial lung disease: a perspective review.

Authors:  Kundan Iqbal; Clive Kelly
Journal:  Ther Adv Musculoskelet Dis       Date:  2015-12       Impact factor: 5.346

Review 2.  Recurrent pneumothorax associated with pulmonary nodules after leflunomide therapy in rheumatoid arthritis: a case report and review of the literature.

Authors:  Sun-Hee Kim; Wan-Hee Yoo
Journal:  Rheumatol Int       Date:  2009-10-28       Impact factor: 2.631

Review 3.  Development of antisynthetase syndrome in a patient with rheumatoid arthritis.

Authors:  Cheol-Kyu Park; Tae-Jong Kim; Young-Nan Cho; Il-Soo Kim; Ho-Jun Lee; Kyung-Eun Lee; Seong-Chang Park; Jong-Sun Kim; Dong-Jin Park; Sung-Ji Lee; Seong-Rye Seo; Jeong-Chul Kim; Sang-Gook Song; Shin-Seok Lee; Yong-Wook Park
Journal:  Rheumatol Int       Date:  2009-10-22       Impact factor: 2.631

Review 4.  Benefit-risk assessment of leflunomide: an appraisal of leflunomide in rheumatoid arthritis 10 years after licensing.

Authors:  Nicola Alcorn; Sarah Saunders; Rajan Madhok
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

5.  Drug induced interstitial lung disease.

Authors:  Martin Schwaiblmair; Werner Behr; Thomas Haeckel; Bruno Märkl; Wolfgang Foerg; Thomas Berghaus
Journal:  Open Respir Med J       Date:  2012-07-27

Review 6.  The multifaceted aspects of interstitial lung disease in rheumatoid arthritis.

Authors:  Lorenzo Cavagna; Sara Monti; Vittorio Grosso; Nicola Boffini; Eva Scorletti; Gloria Crepaldi; Roberto Caporali
Journal:  Biomed Res Int       Date:  2013-09-25       Impact factor: 3.411

Review 7.  Practical Management of Respiratory Comorbidities in Patients with Rheumatoid Arthritis.

Authors:  James Bluett; Meghna Jani; Deborah P M Symmons
Journal:  Rheumatol Ther       Date:  2017-08-14

8.  Leflunomide increases the risk of silent liver fibrosis in patients with rheumatoid arthritis receiving methotrexate.

Authors:  Sang-Won Lee; Hee-Jin Park; Beom Kyung Kim; Kwang-Hyub Han; Soo-Kon Lee; Seung Up Kim; Yong-Beom Park
Journal:  Arthritis Res Ther       Date:  2012-10-29       Impact factor: 5.156

Review 9.  Diffuse alveolar damage in a patient with rheumatoid arthritis under prolonged leflunomide treatment: A Case Report and Literature Review.

Authors:  Li-Ta Keng; Mong-Wei Lin; Hsien-Neng Huang; Kuei-Pin Chung
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

Review 10.  Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows.

Authors:  Giulia Cassone; Andreina Manfredi; Caterina Vacchi; Fabrizio Luppi; Francesca Coppi; Carlo Salvarani; Marco Sebastiani
Journal:  J Clin Med       Date:  2020-04-10       Impact factor: 4.241
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.